FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Pyrazinamide Tablets, USP
Status: Discontinuation
»Therapeutic Categories: Anti-Infective

DAVA Pharmaceuticals Inc. (New 04/20/2020)

Company Contact Information:
800-828-9393, Option 5, then Option 2

Presentation Posting Date Related Information
500 mg, Bottle of 100 (NDC 67253-660-10) 04/20/2020 Distributed by Par Pharmaceuticals.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English